Who invested in ReAlta Life Sciences?
ReAlta Life Sciences's investors include National Institute of Allergy and Infectious Diseases.

United States · Venture startup
Funding summaryUpdated 26 Oct 2026
$40Mraised across 1 round since 2026, from 1 source
ReAlta Life Sciences's investors include National Institute of Allergy and Infectious Diseases.
ReAlta Life Sciences has raised $40M across 1 round since 2026.
ReAlta Life Sciences's most recent round was a Venture of $40M in Apr 2026.
Its most recent round, $40M in Apr 2026, is also its largest on record.
ReAlta Life Sciences's first round on record, in Apr 2026, was backed by National Institute of Allergy and Infectious Diseases.
ReAlta Life Sciences's latest named round is a Venture, in Apr 2026.
ReAlta Life Sciences is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.